Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$39,859,996
-$11,769,417 QoQ
Shares Held
110,074
-25.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#242
of 3,140 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NewEdge Wealth, LLC holds $502,588,092 across 13 Drug Manufacturers - General names. AMGN ranks #6 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
422,116 | $106,221,270 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
754,019 | $95,262,760 | |
| 3 | NVS |
Novartis AG
|
579,486 | $90,817,045 | |
| 4 | LLY |
ELI LILLY & Co
|
64,986 | $77,946,164 | |
| 5 | JNJ |
Johnson & Johnson
|
255,223 | $64,818,985 | |
| 6 | AMGN |
Amgen Inc
This page
|
110,074 | $39,859,996 | |
| 7 | MRK |
Merck & Co., Inc.
|
64,900 | $8,339,650 | |
| 8 | AZN |
Astrazeneca PLC
|
33,124 | $6,280,972 |
All Filings in AMGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,859,996 | 110,074 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $51,629,413 | 146,737 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $46,621,381 | 142,438 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $38,073,577 | 134,917 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $36,548,309 | 130,899 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $36,083,097 | 115,818 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $21,423,565 | 82,196 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $23,548,073 | 73,083 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $21,385,015 | 68,443 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $19,380,104 | 68,163 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $17,594,277 | 61,087 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $14,561,148 | 54,179 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $10,316,603 | 46,467 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $10,602,429 | 43,857 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $10,419,979 | 39,674 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,418,915 | 37,351 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,950,520 | 36,788 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $7,428,468 | 30,719 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,870,392 | 12,759 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $5,918,474 | 27,832 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,545,175 | 26,852 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $6,065,490 | 24,378 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,670,828 | 7,267 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||